Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (Q38445646)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 October 2004
edit
Language Label Description Also known as
English
Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer
scientific article published on 13 October 2004

    Statements

    Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (English)
    John Rinehart
    Alex A Adjei
    Patricia M Lorusso
    David Waterhouse
    J Randolph Hecht
    Ronald B Natale
    Oday Hamid
    Mary Varterasian
    Peggy Asbury
    Eric P Kaldjian
    Stephen Gulyas
    David Y Mitchell
    Roman Herrera
    Judith S Sebolt-Leopold
    Mark B Meyer
    13 October 2004
    4456-4462

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit